Content about McNeil Laboratories

WASHINGTON House Committee on Oversight and Government Reform chairman Ed Towns, D-N.Y., on Thursday announced that the committee will hold a hearing Sept. 30 at 10 a.m. to examine the circumstances surrounding Johnson & Johnson’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.

TARRYTOWN, N.Y. In consultation with the Food and Drug Administration, Blacksmith Brands last week voluntarily recalled all lots of four children's products in the PediaCare line. The products were manufactured for Blacksmith Brands by McNeil Consumer Healthcare at McNeil's Fort Washington, Pa., plant.

The four PediaCare items involved in the recall are:

WASHINGTON According to prepared testimony immediately posted online before members of the Committee on Oversight and Government Reform convened its “Johnson & Johnson Recall of Children’s Tylenol and other Children’s Medicines” hearing Thursday morning, J&J may be under scrutiny for more than the 40 varieties of over-the-counter infant’s and children’s liquid medicines recalled April 30.

FORT WASHINGTON, Pa. McNeil Consumer Healthcare on Friday voluntarily recalled all lots that have not yet expired of certain over-the-counter children’s and infants’ liquid products in consultation with the Food and Drug Administration.

McNeil Consumer initiated the recall because some of these products may not meet required quality standards, though no adverse medical events have been reported, the company stated. “However, as a precautionary measure, parents and caregivers should not administer these products to their children.”